Cargando…

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Grinnan, Daniel, Farkas, Laszlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580684/ https://www.ncbi.nlm.nih.gov/pubmed/30973752 http://dx.doi.org/10.1164/rccm.201902-0388ED

Ejemplares similares

Massive dilatation of the pulmonary artery in association with pulmonic stenosis and pulmonary hypertension
por: Morjaria, Sejal, et al.
Publicado: (2012)

Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness
por: Muzevich, Katie M, et al.
Publicado: (2014)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2016)

Stem Cell–derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
por: Goncharova, Elena A., et al.
Publicado: (2022)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Hudson, Jaylen, et al.
Publicado: (2021)

Utility of plasma volume status in ambulatory patients with pulmonary hypertension
por: Sternberg, Michael E., et al.
Publicado: (2022)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

RNA Signaling in Pulmonary Arterial Hypertension—A Double-Stranded Sword
por: Turton, Helena A., et al.
Publicado: (2020)

Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018)

Natural Immunomodulators 2018
por: Ortuño-Sahagún, Daniel, et al.
Publicado: (2019)

Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension
por: Bhagwani, Aneel R., et al.
Publicado: (2019)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Natural Immunomodulators
por: Ortuño-Sahagún, D., et al.
Publicado: (2017)

Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?
por: Farkas, Laszlo, et al.
Publicado: (2022)

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design
por: Benza, Raymond L., et al.
Publicado: (2022)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Clinical and Experimental Immunomodulation
por: Pavón, Lenin, et al.
Publicado: (2013)

Immunomodulation of Skin Cancer
por: Yusuf, Nabiha
Publicado: (2023)

Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition?
por: Kovacs, Gabor, et al.
Publicado: (2015)

A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care
por: Lee, Joshua D., et al.
Publicado: (2020)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension
por: Ayon, Ramon J., et al.
Publicado: (2023)

Histone Methyl Transferase G9a/GLP—A Novel Avenue in Pulmonary Arterial Hypertension Treatment?
por: Veith, Christine, et al.
Publicado: (2023)

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
por: Link, Patrick A., et al.
Publicado: (2023)

Clinical and Experimental Immunomodulation 2014
por: Pavón, Lenin, et al.
Publicado: (2015)

Clinical and Experimental Immunomodulation 2016
por: Pavón, Lenin, et al.
Publicado: (2017)

Pregnancy in Patients with Pulmonary Arterial Hypertension “To Deliver, or Not to Deliver: That Is the Question”
por: Park, Jae-Hyeong
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7lno6r3ueo5q2na8fqev6lqoqn